Level Four Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Level Four Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Buy	+6,284	New	+$200K	0.01%	813
2023 Q4	–	Sell	-8,945	Closed	-$249K	–	786
2023 Q3	$249K	Buy	8,945 +54	+0.6%	+$1.76K	0.02%	624
2023 Q2	$303K	Sell	8,891 -321	-3%	-$10.1K	0.02%	616
2023 Q1	$277K	Buy	+9,212	New	+$285K	0.02%	602
2022 Q2	–	Sell	-5,538	Closed	-$254K	–	561
2022 Q1	$254K	Sell	5,538 -139	-2%	-$6.63K	0.02%	548
2021 Q4	$348K	Buy	+5,677	New	+$392K	0.03%	485
2021 Q3	–	Sell	-46,504	Closed	-$4.3M	–	474
2021 Q2	$4.3M	Buy	46,504 +6,786	+17%	+$577K	0.3%	78
2021 Q1	$3.52M	Buy	+39,718	New	+$3.94M	0.27%	96

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Level Four Advisory Services's ARKG Position: Q2 2026 in Review

Level Four Advisory Services opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,284 shares worth $264K. The stake represents 0.01% of the portfolio and ranks #813 among its holdings. This is a return to the name: Level Four Advisory Services previously reported a position in ARKG as recently as Q3 2023.

Level Four Advisory Services first reported a position in ARKG in Q1 2021 and has held it in 8 quarters since. The position peaked at $4.3M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Level Four Advisory Services held 6,284 shares of ARK Genomic Revolution ETF worth $264K as of Q2 2026.
ARK Genomic Revolution ETF was a new Level Four Advisory Services position in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #813 holding.
Level Four Advisory Services first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 8 quarters since.
Level Four Advisory Services's ARK Genomic Revolution ETF position peaked at $4.3M in Q2 2021.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.